University of California San Francisco | About UCSF | UCSF Benioff Children's Hospital
Search Site | Find a Doctor
Print this page
FONT SIZE
Home > Doctors > Sue S. Yom

Sue S. Yom, M.D., Ph.D.

Radiation cancer specialist

Dr. Sue Yom is an expert in the radiation treatment and management of head, neck and lung cancers. In her research, she studies chemoradiation for these cancers as well as image-guided radiation therapy and ways to reduce toxicities using focused radiation techniques, emerging biological agents and radiation protectants.

Yom earned a medical degree and Ph.D. at the University of Pennsylvania and completed a residency in radiation oncology at the M.D. Anderson Cancer Center in Houston, Texas. She has received numerous awards recognizing her commitment to patient care and patient-oriented research. She is an assistant professor of radiation oncology at University of California, San Francisco.

Clinics

Radiation Oncology at Mount Zion
1600 Divisadero St., Basement Level
San Francisco, CA 94143-1708
Main Phone: (415) 353-7175
New Patient Appointments: (415) 353-9807
Fax: (415) 353-9884

Hours: Monday to Friday
7 a.m. – 6 p.m.

Radiation Oncology at Parnassus
505 Parnassus Ave, Room L-75
San Francisco, CA 94143-0226
Main Phone: (415) 353-7175
New Patient Appointments: (415) 353-8335
Fax: (415) 353-7281

Hours: Monday to Friday
8 a.m. – 4:30 p.m.

Conditions & Treatments

More about Sue S. Yom

Education

University of Pennsylvania School of Medicine 2002

Residencies

University of Texas Anderson Cancer Center, Radiation Oncology 2007

Selected Research and Publications

  1. Garg MK, Ridge JA, Yom SS, McDonald MW, Quon H, Smith RV, Yeung AR, Lawson J, Saba N, Salama JK, Beitler JJ. Reply, Contralateral irradiation for T(limited) N2bM0 lateralized tonsil cancer. Head Neck. 2013 Mar; 35(3):465-6.
  2. Pejavar S, Yom SS, Hwang A, Speight J, Gottschalk A, Hsu IC, Roach M, Xia P. Computer-Assisted, Atlas-Based Segmentation for Target Volume Delineation in Whole Pelvic IMRT for Prostate Cancer. Technol Cancer Res Treat. 2013 Jun; 12(3):199-206.
  3. Saba NF, Yom SS, Haigentz M, El-Rayes B. Monoclonal Antibodies against Epidermal Growth Factor Receptor in Solid Tumors. Chemother Res Pract. 2012; 2012:291421.
  4. Graff P, Kirby N, Weinberg V, Chen J, Yom SS, Lambert L, Pouliot J. The Residual Setup Errors of Different IGRT Alignment Procedures for Head and Neck IMRT and the Resulting Dosimetric Impact. Int J Radiat Oncol Biol Phys. 2012 Dec 11.
  5. Kono SA, Haigentz M, Yom SS, Saba N. EGFR Monoclonal Antibodies in the Treatment of Squamous Cell Carcinoma of the Head and Neck: A View beyond Cetuximab. Chemother Res Pract. 2012; 2012:901320.
  6. Cooper JS, Zhang Q, Pajak TF, Forastiere AA, Jacobs J, Saxman SB, Kish JA, Kim HE, Cmelak AJ, Rotman M, Lustig R, Ensley JF, Thorstad W, Schultz CJ, Yom SS, Ang KK. Long-term Follow-up of the RTOG 9501/Intergroup Phase III Trial: Postoperative Concurrent Radiation Therapy and Chemotherapy in High-Risk Squamous Cell Carcinoma of the Head and Neck. Int J Radiat Oncol Biol Phys. 2012 Dec 1; 84(5):1198-205.
  7. Yom SS, Chen CP, Jahan TM, Jablons DM. One size does not fit all lung cancer patients. J Thorac Oncol. 2012 May; 7(5):945.
  8. ACR Appropriateness CriteriaŽ ipsilateral radiation for squamous cell carcinoma of the tonsil. Head Neck. 2012 May; 34(5):613-6.
  9. Graff P, Hu W, Yom SS, Pouliot J. Does IGRT ensure target dose coverage of head and neck IMRT patients? Radiother Oncol. 2012 Jul; 104(1):83-90.
  10. Chen CP, Weinberg VK, Jahan TM, Jablons DM, Yom SS. Implications of delayed initiation of radiotherapy: accelerated repopulation after induction chemotherapy for stage III non-small cell lung cancer. J Thorac Oncol. 2011 Nov; 6(11):1857-64.
  11. Yom SS, Garden AS, Staerkel GA, Ginsberg LE, Morrison WH, Sturgis EM, Rosenthal DI, Myers JN, Edeiken-Monroe BS. Sonographic examination of the neck after definitive radiotherapy for node-positive oropharyngeal cancer. AJNR Am J Neuroradiol. 2011 Sep; 32(8):1532-8.
  12. Mannina EM, Pejavar SM, Glastonbury CM, van Zante A, Wang SJ, Yom SS. Diagnosis of Bilateral Tonsil Cancers via Staging PET/CT: Case Report and Review. Int J Otolaryngol. 2011; 2011:928240.
  13. ACR appropriateness criteriaŽ adjuvant therapy for resected squamous cell carcinoma of the head and neck. Oral Oncol. 2011 Jul; 47(7):554-9.
  14. McDonald MW, Lawson J, Garg MK, Quon H, Ridge JA, Saba N, Salama JK, Smith RV, Yeung AR, Yom SS, Beitler JJ. ACR appropriateness criteria retreatment of recurrent head and neck cancer after prior definitive radiation expert panel on radiation oncology-head and neck cancer. Int J Radiat Oncol Biol Phys. 2011 Aug 1; 80(5):1292-8.
  15. Chen CP, Wang SJ, van Zante A, Yom SS. Stepwise regional and distant progression of recurrent pleomorphic adenoma. J Otolaryngol Head Neck Surg. 2011 Feb; 40(1):E5-10.
  16. Kangelaris GT, Yom SS, Huang K, Wang SJ. Limited utility of routine surveillance MRI following chemoradiation for advanced-stage oropharynx carcinoma. Int J Otolaryngol. 2010; 2010.
  17. Quon H, Yom SS, Garg MK, Lawson J, McDonald MW, Ridge JA, Saba N, Salama J, Smith R, Yeung AR, Beitler JJ. ACR Appropriateness Criteria: local-regional therapy for resectable oropharyngeal squamous cell carcinomas. Curr Probl Cancer. 2010 May-Jun; 34(3):175-92.
  18. Faddegon BA, Aubin M, Bani-Hashemi A, Gangadharan B, Gottschalk AR, Morin O, Sawkey D, Wu V, Yom SS. Comparison of patient megavoltage cone beam CT images acquired with an unflattened beam from a carbon target and a flattened treatment beam. Med Phys. 2010 Apr; 37(4):1737-41.
  19. Tsuji SY, Hwang A, Weinberg V, Yom SS, Quivey JM, Xia P. Dosimetric evaluation of automatic segmentation for adaptive IMRT for head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2010 Jul 1; 77(3):707-14.
  20. Park CC, Yom SS, Podgorsak MB, Harris E, Price RA, Bevan A, Pouliot J, Konski AA, Wallner PE. American Society for Therapeutic Radiology and Oncology (ASTRO) Emerging Technology Committee report on electronic brachytherapy. Int J Radiat Oncol Biol Phys. 2010 Mar 15; 76(4):963-72.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions by logging on to UCSF Profiles.

Home • Terms of Use • Site Map • Contact Us       © 2002 - 2013 The Regents of The University of California